pharmaphorum
DECEMBER 16, 2022
Digital therapeutics company Cognoa, which focuses on paediatric behavioural health, announced the appointment of Dr Sharief Taraman as its new CEO. Optibrium, another software developer in the AI drug discovery space, has appointed Ian Smith as its new chief technology officer. McKinnell, Jr. to support the company’s growth.
pharmaphorum
JANUARY 27, 2022
I observed that my colleagues who were working to develop and validate various clinical applications of virtual reality technology had no venue to publish their work in a way that would reach other scientists grappling with the same issues and constraints,” Greenleaf said.
Drug Discovery World
JANUARY 12, 2023
Here, Thomas reflects specifically on Anita Cooper’s prediction relating to the importance of clinical trials. . DDW shared a global data analysis from Phesi, which showed the extent of the impact from the war in Ukraine on clinical development.
Expert insights. Personalized for you.
52 
Let's personalize your content